# Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age

> **NCT01110356** · PHASE4 · COMPLETED · sponsor: **Vifor Pharma** · enrollment: 294 (actual)

## Conditions studied

- Iron Deficiency

## Interventions

- **DRUG:** Ferinject
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT01110356
- **Lead sponsor:** Vifor Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-10
- **Final completion:** 2012-10
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2012-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01110356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01110356, "Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01110356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*